Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Nectar Lifesciences Limited
NECLIFECurrent price
52.8 INR
-1.12 INR (-2.08%)
Last closed
53.92 INR
Company
www.neclife.com
ISIN
INE023H01027
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
National Stock Exchange of India
Capitalization
12 081 316 789 INR
Yield for 12 month
+106.25 %
1Y
3Y
5Y
10Y
15Y
NECLIFE
Nectar Lifesciences Limited manufactures and sells pharmaceutical products in India and internationally. The company's active pharmaceutical ingredients and intermediates comprise cefixime, cefuroxime axetil amorphous, cefuroxime axetil crystalline, cefotaxime sodium, ceftriaxone sodium, cefixime trihydrate, cefuroxime axetil, cefpodoxime proxetil and sterile, cefprozil, cefdinir, cefuroxime sodium, cefazolin sodium, ceftazidime pentahydrate, and cefepime +Arginine. It also offers contract manufacturing for finished dosage forms, such as tablets, capsules, dry powder oral suspensions, and granules and injectable for cephalosporins. In addition, the company provides menthol and pearl capsules. Nectar Lifesciences Limited was incorporated in 1995 and is headquartered in Chandigarh, India. Address: SCO 38-39, Chandigarh, India, 160009
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
3 522.48 INRP/E ratio
201.6154Dividend Yield
–Current Year
+16 853 718 688 INR
Last Year
+15 234 349 987 INR
Current Quarter
+3 592 444 036 INR
Last Quarter
+4 413 063 663 INR
Current Year
+3 379 483 824 INR
Last Year
+3 643 284 192 INR
Current Quarter
+824 978 021 INR
Last Quarter
+947 933 085 INR
Key Figures NECLIFE
1 year
3 years
5 years
10 years
EBITDA
1 580 697 192 INR
Operating Margin TTM
PE Ratio
201.6154
Return On Assets TTM
2.64 %
PEG Ratio
–
Return On Equity TTM
0.47 %
Wall Street Target Price
3 522.48 INR
Revenue TTM
16 490 478 684 INR
Book Value
47.67 INR
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-8.9 %
Dividend Yield
–
Gross Profit TTM
3 643 529 146 INR
Earnings per share
0.26 INR
Diluted Eps TTM
0.26 INR
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
62.5 %
Profit Margin
0.37 %
Dividend Analytics NECLIFE
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
5 %Dividend History NECLIFE
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
21.09.2020
Forward Annual Dividend Yield
–
Last Split Factor
10:1
Payout Ratio
–
Last Split Date
12.11.2008
Dividend Date
–
Stock Valuation NECLIFE
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
201.6154
Forward PE
–
Enterprise Value Revenue
1.0865
Price Sales TTM
0.7132
Enterprise Value EBITDA
10.3584
Price Book MRQ
1.0994
Financials NECLIFE
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators NECLIFE
For 52 weeks
21.5 INR
56.49 INR
50 Day MA
35.17 INR
Shares Short Prior Month
–
200 Day MA
34.27 INR
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart